NC-SYNECHRON
1.4.2016 08:01:26 CEST | Business Wire | Press release
Synechron, one of the fastest growing digital, business consulting and technology service providers, announced its corporate brand integration with Double Effect and Team Trade - companies it had acquired in the past few years, to further augment its consulting and technology capabilities. Post-acquisition, Double Effect and Team Trade were operating as independent entities and brands. However, this brand integration strategy will see both these entities merging into the parent company – Synechron, fortifying the overall consulting and technology business/practice. As part of Synechron’s recently announced ‘Power of 3’ strategy, this move is also aimed at providing all consulting and technology services combined with digital under a single brand umbrella in order to leverage Synechron’s robust brand equity, also fueling its ambition of being a billion dollar company by 2020.
Founded in 2003 in Amsterdam, Double Effect houses 100+ business consultants spread across eight global locations. The Dutch consulting firm works for banking and financial institutions including corporate, investment and retail banks, asset management companies and pension as well as insurance services. In 2013, Double Effect became part of the Synechron group.
Team Trade, founded in 2000, is a Paris-based firm specializing in business consulting and financial software integration. The firm has significant presence in Paris, Luxembourg, Milan, London, New York and Singapore covering the European, North American and Asian markets. Team Trade became part of the Synechron group in December 2014.
“Double Effect’s business consulting portfolio is perfectly aligned with the geographical, business, client and service coverage of Synechron. By operating as a consulting arm of the Synechron brand, all our client relationships and alliances will witness a greater value addition through our combined capabilities. We are very excited about this transformation,” said Bas Heijnen, Managing Director, Double Effec t on this occasion.
“Considering the roll out of the recent business transformation strategy by Synechron, this is the right time for brand integration of Team Trade with Synechron as providing technology and consulting services under the merged identity will have a positive impact in the eyes of clients and other stakeholders,” said Pascal Rellier, Managing Director, Team Trade .
“For Synechron, Double Effect and Team Trade, this mutually beneficial move is a major opportunity for offering a niche, augmented set of technology as well as consulting services for the financial services industry. This brand integration will add more depth to Synechron’s current value proposition and enable our global clients to avail business solutions with a 360-degree perspective, encompassing business consulting and technology combined with digital transformation services under a single roof,” commented Faisal Husain, Co-founder and Chief Executive Officer, Synechron .
This brand integration will come into effect on April 4, 2016 and will be a critical step for Synechron in order to strategically re-align its technology and consulting service capabilities in all its service lines.
About Synechron
Synechron, one of the fastest-growing digital, business consulting & technology services providers, is a $350 million firm based in New York. Since inception in 2001, Synechron has been on a steep growth trajectory. With 5,000+ professionals operating in 16 countries across the world, it has presence across USA, Canada, UK, France, The Netherlands, Switzerland, Luxembourg, Serbia, Germany, Italy, UAE, Singapore, Hong Kong, Japan, Australia and Development Centers in India. Visit us at www.synechron.com .
View source version on businesswire.com: http://www.businesswire.com/news/home/20160331005965/en/
Contact:
Synechron
Atul Tajave
Manager - Global Marketing &
Communication
synechron-mediarelations@synechron.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Netceed Strengthens Board with Global Infrastructure and Technology Leaders1.4.2026 14:00:00 CEST | Press release
Netceed, a global leader in delivering supply chain solutions across broadband, data center and energy infrastructure, today announced the appointment of Franck Bruel, Jan Frykhammar and Stacey Thompson to advise as strategic advisors to its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260401045867/en/ Franck Bruel Following the recently announced recapitalization of the Netceed Group and under the chairmanship of Rajeev Suri, the company is strengthening its Board with globally recognized leaders across telecommunications infrastructure, industrial distribution, energy infrastructure and hyperscale technology. Collectively, the new appointees bring decades of leadership experience across some of the world’s most influential infrastructure and technology companies, reflecting Netceed’s ambition to play a leading role in the next generation of global digital, AI and energy infrastructure. Rajeev Suri, Ch
Vertex Announces US FDA Approval for Label Extensions of ALYFTREK® and TRIKAFTA®, Expanding Availability of These Medicines to ~95% of All People With CF in the United States1.4.2026 13:30:00 CEST | Press release
-With this expansion, any variant that results in production of CFTR protein is now included in the indication for ALYFTREK and TRIKAFTA, reinforcing the impact these medicines have, regardless of the location of the variant in the CFTR protein--Approximately 800 more people with CF in the US are now eligible for a CFTR modulator for the first time- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved expanded use of ALYFTREK® (vanzacaftor/tezacaftor/ivacaftor) for the treatment of people with cystic fibrosis (CF) ages 6 and older with a variant in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that is either responsive based on clinical and/or in vitro data or results in production of CFTR protein. Additionally, the U.S. FDA has also expanded the indication statement for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in patients ages 2 and older. This label expansion was supported b
Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer1.4.2026 13:30:00 CEST | Press release
A Landmark Registrational Study Aiming to Redefine Outcomes in MSS mCRC Which Represents Approximately 95% of Metastatic Colorectal Cancer CasesColorectal Cancer Has Become the Leading Cause of Cancer-related Death in Adults Under Age 50 Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that the first patient has been enrolled in the landmark global phase 3 BATTMAN (CO.33) trial (NCT07152821). This study is evaluating Agenus’ immunotherapy combination of botensilimab (BOT) plus balstilimab (BAL) versus best supportive care in patients with refractory, unresectable microsatellite stable (MSS)/mismatch repair proficient (pMMR) metastatic colorectal cancer (mCRC), a population long considered resistant to immunotherapy. This study is being conducted as a cooperative group trial led by the Canadian Cancer Trials Group (CCTG) from Canada and run across Canada, France, Australia and New Zealand. More than 100 sites will participate across the academic cooper
Klarna Agrees to $1.7 Billion Transaction Supporting up to $40B+ of Lending1.4.2026 13:19:00 CEST | Press release
Klarna, the global digital bank and flexible payments provider, has entered into a new capital efficiency transaction in the form of a Significant Risk Transfer (SRT), covering $1.7 billion-worth of Euro denominated loans and freeing up capital to support continued growth. Klarna has entered into a three-year agreement with a consortium led by Värde Partners. This is Klarna's sixth SRT transaction and improves how effectively Klarna deploys its capital on a global basis. "Our banking license is one of our biggest competitive advantages," said Niclas Neglén, Klarna's Chief Financial Officer. "This is our largest and most efficient SRT transaction to date. These transactions allow us to maximize every unit of capital to support our continued momentum." The transaction follows Klarna’s recently announced $2 billion facility supporting $17B of US Financing expansion. About Klarna Klarna is a global digital bank and flexible payments provider. With over 118 million global active Klarna user
Americhem Launches nDryve™: PFAS-Free In-Melt Technology Platform for Functional Fibers1.4.2026 13:00:00 CEST | Press release
Americhem, Inc., a global polymer solutions provider, today announced the launch of nDryve™, a PFAS-free, in-melt surface-modifying technology platform designed to deliver durable multi-fluid repellency against alcohol and other low-surface-energy fluids in fiber systems. As global regulations accelerate the phase-out of per- and polyfluoroalkyl substances (PFAS), manufacturers are under increasing pressure to maintain barrier performance without fluorinated chemistries. nDryve™ was developed to address this shift, offering a PFAS-free, in-melt alternative to conventional surface applied treatments. Engineered for Performance Without PFAS Often referred to as “forever chemicals,” PFAS have come under heightened regulatory scrutiny due to their persistence and potential environmental and health impacts. nDryve™ integrates directly into the polymer during melt processing, embedding surface-modifying functionality within the fiber matrix rather than relying on removable finishes. By engin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
